Ahmed Hnoosh

Director - Worldwide Health Economics & Outcomes Research Bristol Myers Squibb

Ahmed Hnoosh is a global health economics and outcomes research leader at Bristol Myers Squibb, where he leads the development of pricing, reimbursement, and value strategies across international markets. He specialises in translating clinical innovation into compelling economic evidence, supporting successful access and reimbursement across diverse healthcare systems. Ahmed has led global HTA submissions, managed entry agreements, and real-world evidence programmes, working cross-functionally to align medical, commercial, and payer priorities. His work focuses on closing the gap between innovation and access by ensuring therapies demonstrate measurable value to healthcare systems, payers, and patients.

Seminars

Tuesday 20th October 2026
Operationalising Real World Evidence in Early Access Programmes: Designing Fit-for-Purpose, Low-Burden Data Collection
4:00 pm
  • Designing data collection approaches that remain within the treatment context and do not interfere with clinical trials
  • Identifying what data is truly valuable to collect within EAPs vs where alternative approaches are more appropriate
  • Building low-burden, scalable data capture frameworks for physicians and patients
  • Translating EAP data into tangible value (e.g. informing safety, dosing, HTA, or prelaunch decision making)
Ahmed Hnoosh - 5th Operationalise Early Access Programmes Europe